CRN has announced new board chair, executive officers, and newly elected board members

Photo © iStockphoto.com/skynesher

The Council for Responsible Nutrition (CRN; Washington, D.C.) has announced that Tara Martin, general counsel, Nutrawise/YouTheory, will serve as the association’s new board of directors chair, starting in January 2023. Martin succeeds Barry Ritz, PhD, chief scientific officer and vice president, professional R&D and regulatory affairs for Nestlé Health Science. Ritz served in the role for the last two years and will serve on the board as CRN’s Immediate Past Chair.

“We are pleased to announce Tara Martin’s tenure as CRN board of directors chair in 2023,” said CRN president and CEO Steve Mister, in a press release. “As a board member, she has been essential in steering CRN decision making on critical issues affecting the dietary supplement and functional food industry. I look forward to working closely with her during the next two years. I also thank Barry for his leadership, particularly around the #Act4Access initiative, which raised awareness of how CRN members are actively working toward access to nutrition and nutrition education for all and helped mobilize more members in the fight against hunger.”

Other elected members of the board include:

• Bruce Brown, vice president and general manager, nutrition and supplements, Kerry (Chair Elect)
• Mandy Kraynik, vice president, innovation, Nature’s Way (Treasurer)
• Mark Walsh, CEO, MeriCal (Secretary)
• Barry Ritz, Ph.D., Nestlé Health Science (Immediate Past Chair)
• Harvey Kamil, Piping Rock (Chair Emeritus)

Serving on CRN’s executive committee for 2023-24 will be:

• Aaron Bartz, Ortho Molecular
• Aaron Bennett, Vytalogy
• Christine Burdick-Bell, Pharmavite
• Eric Choban, DSM
• Mike Finamore, Gemini Pharmaceutical
• Jennifer Holahan, Haleon
• Lisa Pankiewicz, Clorox
• Michelle Stout, Amway
• Karen Todd, Kyowa Hakko
• Mike Yatcilla, Ph.D., Herbalife Nutrition

CRN members have also elected five members of the Board of Directors for three-year terms. Representing the finished products marketers/manufacturers segment will be Doug Brown, vice president, Americas, Sirio Nutrition Co. Ltd., and Andrew Shao, PhD, senior vice president, global scientific and regulatory affairs, Chromadex. Justin Green, PhD, director of scientific affairs at Embria Health Sciences (re-elected), John Helfrick, director of human nutrition, BASF Corp. (re-elected) and Deshanie Rai, PhD, vice president, global scientific and regulatory affairs, OmniActive Health Technologies will represent the ingredient suppliers segment.